BCL2 and central nervous system cancer: Western blot analysis and IHC showed that cyclin D1, cyclin D2, CDK4, CDK6, Ki-67, Bcl-2 and Bax were involved in the NRXN3-induced inhibitory effect on glioma growth (Figs. 7D, E and S6A).